(Full-year report 2022)
(Current pipeline on website as of 2023)
The program is split into two separate streams, the ligament indication is still pending large animal study as they suggested in their report initially.
The other stream is progressing into further human trials after the previous results.
You're mixing up the streams, they haven't released any animal study data because there is none.
- Forums
- ASX - By Stock
- Ann: Investor Presentation
(Full-year report 2022)(Current pipeline on website as of...
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
40.0¢ |
Change
0.030(8.11%) |
Mkt cap ! $83.73M |
Open | High | Low | Value | Volume |
39.0¢ | 40.5¢ | 38.5¢ | $284.0K | 720.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 22248 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 208719 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 10275 | 0.400 |
3 | 22248 | 0.390 |
1 | 2500 | 0.385 |
5 | 71825 | 0.380 |
5 | 44000 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 190562 | 5 |
0.405 | 35836 | 2 |
0.410 | 94785 | 6 |
0.415 | 3200 | 1 |
0.420 | 6825 | 2 |
Last trade - 15.58pm 11/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
OCC (ASX) Chart |